SCHEMBL6259368

SCHEMBL6259368

COc1ccc(CCC(O)CN2C[CH]N(C3CCCC3)CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC18A2 Q05940 1/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
CYP2D6 P10635 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HTT P42858 2/20 0.41
HRH3 Q9Y5N1 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
DRD4 P21917 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256508 0.99 KMT2A (0.44) SLC18A2KMT2AALDH1A1TSHRCYP2D6
SCHEMBL6256736 0.89 CYP2D6 (0.55) SLC18A2KMT2AALDH1A1TSHRCYP2D6
SCHEMBL5222045 0.88 CYP2D6 (0.54) SLC18A2KMT2AALDH1A1TSHRCYP2D6
SCHEMBL4490566 0.74 CYP1A2 (0.55) KMT2AALDH1A1TSHRCYP2D6SIGMAR1
SCHEMBL6258338 0.73 KCNH2 (0.47) KMT2ACYP2D6SIGMAR1HTTLMNA
SCHEMBL4509510 0.73 CYP1A2 (0.57) ALDH1A1TSHRCYP2D6SIGMAR1KDM4E
SCHEMBL6261178 0.71 MEN1 (0.47) KMT2AALDH1A1CYP2D6SIGMAR1KDM4E
SCHEMBL6259496 0.70 RAB9A (0.54) KMT2AALDH1A1TSHRCYP2D6KDM4E
SCHEMBL7277594 0.69 HTT (0.56) KMT2AALDH1A1HTTMEN1
SCHEMBL4498990 0.65 MEN1 (0.63) KMT2AALDH1A1CYP2D6POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578737-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-09-28 EP disclosed
WO-2004063180-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2004-07-29 WO disclosed